
Congress trades
Perrigo Company plc (PRGO)
NYSE · Healthcare · 71 congress trades · last filed 3 years ago
About Perrigo Company plc
from the company's filings and listing- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Chief executive
- Albert A. Manzone
- Employees
- 8,100
- Listed since
- Dec 17, 1991
- Market value
- $2.0B
- Price to earnings
- -
- Earnings per share
- -$12.47
- Dividend yield
- 8.09%
Earnings
6 reported quarters · next on Nov 4, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 5, 2026 | $0.50 | $0.39 | $1.0B | $1.0B | EPS beatRevenue in line |
| Q1 FY2026reported May 6, 2026 | $0.43 | $0.39 | $969.2M | $1.0B | EPS beatRevenue miss |
| Q4 FY2025reported Feb 26, 2026 | $0.77 | $0.80 | $1.1B | $1.1B | EPS missRevenue in line |
| Q3 FY2025reported Nov 5, 2025 | $0.80 | $0.75 | $1.0B | $1.1B | EPS beatRevenue miss |
| Q2 FY2025reported Aug 6, 2025 | $0.57 | $0.59 | $1.1B | $1.1B | EPS missRevenue miss |
| Q1 FY2025reported May 7, 2025 | $0.60 | $0.56 | $1.0B | $1.1B | EPS beatRevenue miss |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Mar 20, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Patrick Lockwood-TaylorCEO, President | $1.2M | $7.0M | $829K | $9.0M |
| Eduardo BezerraEVP, CFO | $778K | $2.5M | $350K | $3.7M |
| Roberto KhouryEVP, Chief Commercial Officer | $659K | $2.2M | $329K | $3.1M |
| Abbie LennoxEVP, Chief Scientific Officer | $648K | $1.3M | $1.0M | $3.0M |
| Charles AtkinsonEVP, General Counsel and Secretary | $760K | $1.9M | $288K | $2.9M |
The summary compensation table from the 2025 proxy statement, current executives only. 2 executives who have since left the company are named in that filing and not shown here. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $235.9M | 22,703,127 | +32.6% | 16.32% |
| Neuberger Berman Group LLC | $111.0M | 10,680,100 | +2.1% | 7.68% |
| Vanguard Portfolio Management LLC | $94.0M | 9,045,661 | +11.1% | 6.50% |
| Price T Rowe Associates Inc | $90.4M | 8,700,421 | -35.0% | 6.25% |
| State Street Corp | $88.7M | 8,528,704 | +18.0% | 6.13% |
| Fuller & Thaler Asset Management, Inc. | $77.9M | 7,498,227 | -2.1% | 5.39% |
| Vanguard Capital Management LLC | $64.9M | 6,245,418 | +0.6% | 4.49% |
| Invesco Ltd. | $61.0M | 5,866,702 | +24.5% | 4.22% |
| Dimensional Fund Advisors LP | $56.8M | 5,467,098 | -16.8% | 3.93% |
| Menora Mivtachim Holdings Ltd. | $45.7M | 4,394,318 | +13.5% | 3.16% |
| Geode Capital Management, LLC | $37.6M | 3,622,308 | +58.1% | 2.60% |
| AQR Capital Management LLC | $35.3M | 3,480,666 | +409.8% | 2.50% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
Congress trades in PRGO
20 disclosures of 71 on record · median 36d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | -56.9%S&P +74.4% · vs S&P 500 -131.3% | Jun 28, 2023 | Jul 19, 2023 | 21d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -56.7%S&P +78.9% · vs S&P 500 -135.5% | Jun 5, 2023 | Jul 19, 2023 | 44d |
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | -57.4%S&P +74.4% · vs S&P 500 -131.8% | Jun 29, 2023 | Jul 19, 2023 | 20d |
| Michael T. McCaulFiled late | Stock | Sale | $1,001 - $15,000 | -55.3%S&P +81.1% · vs S&P 500 -136.5% | Jun 1, 2023 | Jul 19, 2023 | 48d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -57.3%S&P +75.7% · vs S&P 500 -133.0% | Jun 23, 2023 | Jul 19, 2023 | 26d |
| Michael T. McCaulFiled late | Stock | Sale | $15,001 - $50,000 | -55.3%S&P +81.1% · vs S&P 500 -136.5% | Jun 1, 2023 | Jul 19, 2023 | 48d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -56.9%S&P +74.4% · vs S&P 500 -131.3% | Jun 28, 2023 | Jul 19, 2023 | 21d |
| Michael T. McCaulFiled late | Stock | Sale | $1,001 - $15,000 | -56.6%S&P +78.5% · vs S&P 500 -135.1% | Jun 2, 2023 | Jul 19, 2023 | 47d |
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | -56.7%S&P +78.9% · vs S&P 500 -135.5% | Jun 5, 2023 | Jul 19, 2023 | 44d |
| Michael T. McCaulFiled late | Stock | Sale | $15,001 - $50,000 | -56.6%S&P +78.5% · vs S&P 500 -135.1% | Jun 2, 2023 | Jul 19, 2023 | 47d |
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | -58.1%S&P +74.4% · vs S&P 500 -132.4% | Jun 22, 2023 | Jul 19, 2023 | 27d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -57.2%S&P +76.4% · vs S&P 500 -133.6% | Jun 26, 2023 | Jul 19, 2023 | 23d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -58.1%S&P +74.4% · vs S&P 500 -132.4% | Jun 22, 2023 | Jul 19, 2023 | 27d |
| Michael T. McCaul | Stock | Sale | $100,001 - $250,000 | -59.3%S&P +85.6% · vs S&P 500 -145.0% | May 12, 2023 | Jun 22, 2023 | 41d |
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | -57.2%S&P +82.3% · vs S&P 500 -139.4% | May 18, 2023 | Jun 22, 2023 | 35d |
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | -56.4%S&P +84.0% · vs S&P 500 -140.5% | May 17, 2023 | Jun 22, 2023 | 36d |
| Michael T. McCaul | Stock | Sale | $50,001 - $100,000 | -57.2%S&P +82.3% · vs S&P 500 -139.4% | May 18, 2023 | Jun 22, 2023 | 35d |
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | -59.3%S&P +85.6% · vs S&P 500 -145.0% | May 12, 2023 | Jun 22, 2023 | 41d |
| Michael T. McCaul | Stock | Sale | $50,001 - $100,000 | -56.4%S&P +84.0% · vs S&P 500 -140.5% | May 17, 2023 | Jun 22, 2023 | 36d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | -63.5%S&P +92.2% · vs S&P 500 -155.7% | May 25, 2022 | Jun 14, 2022 | 20d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 9, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Questions
Which members of Congress have traded PRGO?
Michael T. McCaul disclosed PRGO transactions in the filings shown here.
How quickly are PRGO trades disclosed?
Congressional disclosures took a median of 36 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.
